发明名称 |
Method for treating obesity |
摘要 |
The present invention is directed to methods for treating obesity, reducing excessive body weight, treating an obesity-related condition, treating unwanted localized fat deposits, and treating areas of cellulite. The method comprises the steps of first identifying a subject in need thereof, and administering to the subject an effective amount of rhamnolipids. A pharmaceutical composition comprising rhamnolipids can be applied by any accepted mode of administration including oral, intranasal, subcutaneous, percutaneous, intravenous, or intracutaneous administration. |
申请公布号 |
US8765694(B2) |
申请公布日期 |
2014.07.01 |
申请号 |
US201313946931 |
申请日期 |
2013.07.19 |
申请人 |
Rhamnopharma Inc. |
发明人 |
Leighton Anton |
分类号 |
A01N43/04;A61K31/70;A61K31/715 |
主分类号 |
A01N43/04 |
代理机构 |
Perkins Coie LLP |
代理人 |
Perkins Coie LLP ;Kung Viola T. |
主权项 |
1. A method for reducing excessive body weight from a mammal subject suffering from excessive weight or overt obesity, comprising the steps of identifying a subject suffering from excessive weight or overt obesity, and administering to the subject an effective amount of rhamnolipids, wherein said rhamnolipids are selected from the group consisting of: α-L-rhamnosyl-β-hydroxydecanoyl-β-hydroxydecanoate, α-L-rhamnosyl-(1,2)-α-L-rhamnosyl-β-hydroxydecanoyl-β-hydroxydecanoate, α-L-rhamnopyranosyl-(1,2)-α-L-rhamnopyranosyl-β-hydroxydecanoyl-β-hydroxydodecanoate; α-L-rhamnopyranosyl-(1,2)-α-L-rhamnopyranosyl-β-hydroxytetradecanoyl-β-hydroxytetradecanoate, or a combination thereof. |
地址 |
Oakland CA US |